Comparison of detection of arrhythmias in patients with chronic heart failure secondary to non-ischemic versus ischemic cardiomyopathy by 1 versus 7-day Holter monitoring

American Journal of Cardiology

Volumn 106, Issue 5, 2010, Pages 677-681

  Pastor Pérez, Francisco J ^a   Manzano Fernández, Sergio ^a   Goya Esteban, Rebeca ^b   Pascual Figal, Domingo A ^a   Barquero Pérez, Oscar ^b   Rojo Álvarez, Jose Luis ^b   Martinez Espejo, Maria Dolores Martinez ^a   Chavarri, Mariano Valdés ^a   García Alberola, Arcadio ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; DIAGNOSTIC ACCURACY; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HOLTER MONITORING; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA; ARRHYTHMIAS, CARDIAC; COHORT ANALYSIS; COMPARATIVE STUDY; COMPLICATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PREVALENCE; PROCEDURES; TIME;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; COHORT STUDIES; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PREVALENCE; STROKE VOLUME; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77955926499     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.04.027     Document Type: Article

References (27)

1. K. Dickstein, A. Cohen-Solal, G. Filippatos, C. Funck-Brentano, I. Hellemans, S.D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J.L. Zamorano, M. Tendera, A. Auricchio, J. Bax, M. Bohm, U. Corra, B.P. della, P.M. Elliott, F. Follath, M. Gheorghiade, Y. Hasin, A. Hernborg, T. Jaarsma, M. Komajda, R. Kornowski, M. Piepoli, B. Prendergast, L. Tavazzi, J.L. Vachiery, F.W. Verheugt, J.L. Zamorano, and F. Zannad ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 2008 933 989
2. ATS statement: guidelines for the six-minute walk test Am J Respir Crit Care Med 166 2002 111 117
3. T.S. Rector, J.N. Cohn Pimobendan Multicenter Research Group Assessment of patient outcome with the Minnesota Living With Heart Failure Questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan Am Heart J 124 1992 1017 1025
4. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M.S. Sutton, and W.J. Stewart Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
5. F. Badilini The ISHNE Holter standard output file format Ann Noninvas Electrocardiol 3 1998 263 266
6. Pathfinder 710 family data formats customer definition Issue 5 May 2001 Reynolds Medical Edinburgh, United Kingdom
7. S. Masson, and R. Latini Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure Am J Cardiol 101 2008 56 60
8. A.S. Go, E.M. Hylek, K.A. Phillips, Y. Chang, L.E. Henault, J.V. Selby, and D.E. Singer Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375
9. T.J. Wang, M.G. Larson, D. Levy, R.S. Vasan, E.P. Leip, P.A. Wolf, R.B. D'Agostino, J.M. Murabito, W.B. Kannel, and E.J. Benjamin Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study Circulation 107 2003 2920 2925
10. P.D. Ziegler, J.L. Koehler, and R. Mehra Comparison of continuous versus intermittent monitoring of atrial arrhythmias Heart Rhythm 3 2006 1445 1452
11. Dagres N, Kottkamp H, Piorkowski C, Weis S, Arya A, Sommer P, Bode K, Gerds-Li JH, Kremastinos DT, Hindricks G. Influence of the duration of Holter monitoring on the detection of arrhythmia recurrences after catheter ablation of atrial fibrillation implications for patient follow-up. Int J Cardiol. In press.
12. D. Jabaudon, J. Sztajzel, K. Sievert, T. Landis, and R. Sztajzel Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack Stroke 35 2004 1647 1651
13. J.T. Bigger Jr, J.L. Fleiss, and L.M. Rolnitzky Prevalence, characteristics and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction Am J Cardiol 58 1986 1151 1160
14. H.C. Doval, D.R. Nul, H.O. Grancelli, S.D. Varini, S. Soifer, G. Corrado, S. Dubner, O. Scapin, S.V. Perrone GESICA-GEMA Investigators Nonsustained ventricular tachycardia in severe heart failure Independent marker of increased mortality due to sudden death Circulation 94 1996 3198 3203
15. A.P. Maggioni, G. Zuanetti, M.G. Franzosi, F. Rovelli, E. Santoro, L. Staszewsky, L. Tavazzi, and G. Tognoni Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era GISSI-2 results Circulation 87 1993 312 322
16. L. Monserrat, P.M. Elliott, J.R. Gimeno, S. Sharma, M. Penas-Lado, and W.J. McKenna Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients J Am Coll Cardiol 42 2003 873 879
17. W. Grimm, M. Christ, and B. Maisch Long runs of non-sustained ventricular tachycardia on 24-hour ambulatory electrocardiogram predict major arrhythmic events in patients with idiopathic dilated cardiomyopathy Pacing Clin Electrophysiol 28 suppl 2005 S207 S210
18. S.N. Singh, S.G. Fisher, P.E. Carson, R.D. Fletcher Department of Veterans Affairs CHF STAT Investigators Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy J Am Coll Cardiol 32 1998 942 947
19. N.D. Brunetti, G. D'Arienzo, G. Tiscia, P.L. Pellegrino, L. De Gennaro, and M. Di Biase 24 h and prolonged ambulatory ECG recording in patients with ventricular ectopy: maybe 24 h are not enough? Int J Cardiol 127 2008 247 251
20. R. Berger, M. Huelsman, K. Strecker, A. Bojic, P. Moser, B. Stanek, and R. Pacher B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 2002 2392 2397
21. H. Blangy, N. Sadoul, B. Dousset, A. Radauceanu, R. Fay, E. Aliot, and F. Zannad Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction Europace 9 2007 724 729
22. J.M. Tapanainen, K.S. Lindgren, T.H. Makikallio, O. Vuolteenaho, J. Leppaluoto, and H.V. Huikuri Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era J Am Coll Cardiol 43 2004 757 763
23. A. Verma, F. Kilicaslan, D.O. Martin, S. Minor, R. Starling, N.F. Marrouche, S. Almahammed, O.M. Wazni, S. Duggal, R. Zuzek, H. Yamaji, J. Cummings, M.K. Chung, P.J. Tchou, and A. Natale Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies Heart 92 2006 190 195
24. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, R. Boineau, M. Domanski, C. Troutman, J. Anderson, G. Johnson, S.E. McNulty, N. Clapp-Channing, L.D. Davidson-Ray, E.S. Fraulo, D.P. Fishbein, R.M. Luceri, and J.H. Ip Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
25. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, D.S. Cannom, J.P. Daubert, S.L. Higgins, M.W. Brown, and M.L. Andrews Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
26. A.E. Buxton, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prystowsky, G. Hafley Multicenter Unsustained Tachycardia Trial Investigators A randomized study of the prevention of sudden death in patients with coronary artery disease N Engl J Med 341 1999 1882 1890
27. A.J. Moss, W.J. Hall, D.S. Cannom, J.P. Daubert, S.L. Higgins, H. Klein, J.H. Levine, S. Saksena, A.L. Waldo, D. Wilber, M.W. Brown, M. Heo Multicenter Automatic Defibrillator Implantation Trial Investigators Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia N Engl J Med 335 1996 1933 1940